Welcome to APhA's Education Library


Click links below for more information

  • Can be sorted by Newest or By Title . (The titles are listed alphabetically.)
  • Goals / objectives of the course can be seen by clicking on the title
  • Enroll and/or purchase the course by clicking on Enroll Now or Add To Cart
  • Once purchased. the course will be found under My Training
  • TIP: Use the search engine, or scroll down to bottom and select 50 per page .
If you have registered for the APhA program through one of our licensed partners which is hosting the APhA Program - that Organization's coordinator will provide you with an enrollment code to gain access to the required course materials. You can redeem your enrollment code at My Training

APhA's Education Library

Found 179
Sort by
Home Study
Member Free
Non-Member $25.00

Health Information Technology in Practice and the Journey Towards Interoperability

A review of health information technology, utilization, and impact in pharmacy settings.
informatics technology quality improvement
Home Study
Member Free
Non-Member Free

APhA Quick Quiz: Essential Diabetes Updates

Complete these 5 multiple-choice questions to broaden your knowledge on recent changes to national standards of care for the optimal treatment of type 2 diabetes.
national guidelines Diabetes DM antidiabetic agents Evidence-based Medicine
Advanced Training
Member $125.00
Non-Member $275.00

Using Evidence to Advance Your Practice (2nd Edition)

This program will help pharmacists to understand the principles and process of evidence-based practice to begin to integrate information from patients and the literature to make decisions about individual patients.
management informatics medication therapy management research documentation
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2017: Part 3

Learn about indications, mechanisms of action, and information on dosage and administration for these new agents, as well as their most important pharmacokinetic properties, adverse events, and other risks and precautions.
antiparasitic agents adverse drug reactions antibacterial agents new drugs drug dosing
Home Study
Member Free
Non-Member $129.00

What’s All the Hype Behind Hypertension? (Home Study)

Enroll in this archived “Hot Topics” webinar to get an overview on recent updates and recommended medication regimens for treatment of high blood pressure based on ACC-AHA 2017 Hypertension Guidelines.
hypertension cholesterol management Evidence-based Medicine
Home Study
Member Free
Non-Member N/A

The Skinny on Weight Loss: A Review of Pharmacological Obesity Management (Home Study)

This archived webinar will review pharmacologic anti-obesity options, including the newest agents and their place in therapy for the management of overweight/obese adults.
obesity anorexiants stimulants antiobesity agents over-the-counter treatment weight management
Home Study
Member Free
Non-Member $25.00

Precision Medicine and Pharmacogenomics in Community and Primary Care Settings

Come gain insight on the utility and practicality of implementing a pharmacist-driven pharmacogenomics program.
Laboratory Pharmacogenomics Evidence-based Medicine
Home Study
Member Free
Non-Member $25.00

APhA Pharmacy Law Matters: A Year in Review Legal and regulatory developments affecting pharmacy in 2017

Check out A YEAR IN REVIEW 2017...A continuing pharmacy education activity for pharmacists and pharmacy technicians!
Opioids USP Chapter 800 Food and Drug Administration (FDA) law regulation USP Chaper 797
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2017: Part 2

Don't miss the opportunity to gain information about the most important properties of new FDA-approved therapeutic agents marketed in 2017.
antiarthritic agents adverse drug reactions new drugs antiviral agents anticoagulant agents antibiotics drug information constipation
Home Study
Member Free
Non-Member $129.00

LDL-C and ASCVD Risk Reduction: The Utility of PCSK9 Inhibitors (Home Study)

Participate in the online learning activity to (1) gain a better understanding on the role of PCSK9 inhibitors in cardiovascular risk reduction and (2) provide guidance to patients that would benefit from this treatment.
cholesterol lowering agents cardiovascular disease dyslipidemia